Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer

Overview of attention for article published in BMC Immunology, April 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,011 followers.

#Therapeutic_cancer #vaccine: phase I #clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell #lung_cancer. https://t.co/IctyaeFP2a #submit your #abstract at https://t.co/3VAjvE5bcv #clinical_immunology_con

18 Jun 2018

Reply Repost Favourite

Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer https://t.co/kADn4B5M5z https://t.co/xFz0HAZVyP

17 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.